<?xml version="1.0" encoding="UTF-8"?>
<ref id="ddr21709-bib-0128">
 <mixed-citation publication-type="journal" id="ddr21709-cit-0128">
  <string-name>
   <surname>Monteil</surname>, 
   <given-names>V.</given-names>
  </string-name>, 
  <string-name>
   <surname>Kwon</surname>, 
   <given-names>H.</given-names>
  </string-name>, 
  <string-name>
   <surname>Prado</surname>, 
   <given-names>P.</given-names>
  </string-name>, 
  <string-name>
   <surname>Hagelkrüys</surname>, 
   <given-names>A.</given-names>
  </string-name>, 
  <string-name>
   <surname>Wimmer</surname>, 
   <given-names>R. A.</given-names>
  </string-name>, 
  <string-name>
   <surname>Stahl</surname>, 
   <given-names>M.</given-names>
  </string-name>, &amp; 
  <string-name>
   <surname>Penninger</surname>, 
   <given-names>J. M.</given-names>
  </string-name> (
  <year>2020</year>). 
  <article-title>Inhibition of SARS‐CoV‐2 infections in engineered human tissues using clinical‐grade soluble human ACE2</article-title>. 
  <source xml:lang="en">Cell</source>, 
  <volume>181</volume>, 
  <fpage>905</fpage>–
  <lpage>913.e7</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.cell.2020.04.004</pub-id>
  <pub-id pub-id-type="pmid">32333836</pub-id>
 </mixed-citation>
</ref>
